Nicos Karasavvas

4.3k citations
26 papers · 799 indexed · h-index 15
Topics
HIV Research and Treatment (11 papers)Immunotherapy and Immune Responses (5 papers)Virus-based gene therapy research (4 papers)

In The Last Decade

Nicos Karasavvas

25 papers receiving 775 citations

Peers

Nicos Karasavvas
Comparison fields: 5 of 90
  • Immunology 306
  • Molecular Biology 288
  • Virology 206
  • Oncology 121
  • Nutrition and Dietetics 114
Replace Fabienne Aillet with:
Fabienne Aillet Spain
Eckart Köttgen Germany
Jun Nagafune Japan
Lisa M. Chelstrom United States
Carla E. Cano France
Concetta Pietropaolo Italy
J M Bjorndahl United States
Anna Maria Ferraris Italy
Dieter Häussinger Germany
Walter Fiers Belgium
Nicos Karasavvas relative to Fabienne Aillet Spain Fabienne Aillet's profile →
Citations per field
00.5×3.5×
Fabienne Aillet · 1×
Citations per year

Countries citing papers authored by Nicos Karasavvas

Since Specialization
Citations

This map shows the geographic impact of Nicos Karasavvas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicos Karasavvas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicos Karasavvas more than expected).

Fields of papers citing papers by Nicos Karasavvas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicos Karasavvas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicos Karasavvas. The network helps show where Nicos Karasavvas may publish in the future.

Co-authorship network of co-authors of Nicos Karasavvas

This figure shows the co-authorship network connecting the top 25 collaborators of Nicos Karasavvas. A scholar is included among the top collaborators of Nicos Karasavvas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicos Karasavvas. Nicos Karasavvas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 16
4 11
5 27
6 10
7 25
8 4
9 25
10 3
11 169
12 59
13 13
14 15
15 57
16 53
17 1
18 24
19 69
20 87

About Nicos Karasavvas

Nicos Karasavvas is a scholar working on Virology, Immunology and Infectious Diseases, having authored 26 papers that have together received 799 indexed citations. Recurring topics across this work include HIV Research and Treatment (11 papers), Immunotherapy and Immune Responses (5 papers) and Virus-based gene therapy research (4 papers). The work is most often cited by research in Virology (206 citations), Immunology (306 citations) and Dermatology (73 citations). Nicos Karasavvas has collaborated with scholars based in United States, Thailand and Canada. Frequent co-authors include David W. Golde, Carl R. Alving, Gary R. Matyas, Zoltán Beck, Mark Heaney, Zahra Zakeri, Emily A. Smith, David A. Scheinberg, Jeffrey R. Gardner and Owen A. O’Connor. Their work appears in journals such as The Journal of Experimental Medicine, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026